MedTrace Logo

New-Onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China

NCT05511649 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 832

Last updated 2026-03-19

No results posted yet for this study

Summary

To investigate the prognostic impacts of the atrial fibrillation burden (AFb) in acute myocardial infarction (AMI) patients who developed paroxysmal new-onset atrial fibrillation (NOAF) during the index AMI hospitalization.

Conditions

  • New Onset Atrial Fibrillation
  • Acute Myocardial Infarction

Interventions

DEVICE

continuous electronic monitor

All patients with MI hospitalized in the CCU department of Shanghai Tenth People's Hospital, KaiFeng Central Hospital, and the First Affiliated Hospital of Zhengzhou University will receive 24-hour continuous cardiac monitoring until discharge.

Sponsors & Collaborators

  • Kaifeng Central Hospital

    collaborator OTHER

  • The First Affiliated Hospital of Zhengzhou University

    collaborator OTHER

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Yidong Wei, M.D., Ph.D. · Shanghai 10th People's Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2023-07-27
Completion
2023-09-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05511649 on ClinicalTrials.gov